Operating Cash Flow
Gilead Sciences Operating Cash Flow decreased by 23.5% to $2.54B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 44.8%, from $1.76B to $2.54B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -3.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Consistently high operating cash flow indicates a healthy, self-sustaining business capable of funding its own growth and returning capital to shareholders.
Detailed definition
Net cash from operating activities measures the total amount of cash generated by a company's core business operations....
Peer comparison
Investors often compare this to capital expenditures to calculate Free Cash Flow, a primary valuation metric for mature tech giants.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.32B | $3.25B | $3.21B | $1.84B | $1.80B | $2.86B | $2.57B | $1.74B | $2.34B | $1.76B | $2.17B | $2.22B | $1.33B | $4.31B | $2.98B | $1.76B | $827.00M | $4.11B | $3.33B | $2.54B |
| QoQ Change | — | +40.5% | -1.5% | -42.6% | -2.1% | +58.9% | -10.3% | -32.1% | +34.1% | -24.9% | +23.6% | +2.3% | -40.3% | +225.2% | -31.0% | -40.9% | -52.9% | +396.7% | -19.0% | -23.5% |
| YoY Change | — | — | — | — | -22.2% | -12.0% | -19.9% | -5.2% | +29.7% | -38.7% | -15.5% | +27.2% | -43.3% | +145.5% | +37.2% | -20.8% | -37.6% | -4.7% | +11.8% | +44.8% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's operating cash flow?
- Gilead Sciences (GILD) reported operating cash flow of $2.54B in Q1 2026.
- How has Gilead Sciences's operating cash flow changed year-over-year?
- Gilead Sciences's operating cash flow increased by 44.8% year-over-year, from $1.76B to $2.54B.
- What is the long-term trend for Gilead Sciences's operating cash flow?
- Over 4 years (2021 to 2025), Gilead Sciences's operating cash flow has grown at a -3.1% compound annual growth rate (CAGR), from $11.38B to $10.02B.
- What does operating cash flow mean?
- The actual amount of cash a company brings in from its day-to-day business activities.